Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year
It’s unclear whether a deepening trade rift with the US could slow the stream of cash from China to medical innovation hubs such as Silicon Valley and Cambridge, Massachusetts
Follow your favourite topic and get notified
Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
